JENNIFER MCDONNELL: Open Payments
NPI 1952470726 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 19 payments from 12 companies in 2025. Trend: 2023 $721 · 2024 $656 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $95 |
| QOL Medical, LLC | 1 | $49 |
| ABBVIE INC. | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Exact Sciences Corporation | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: TREMFYA, ENTYVIO, Sucraid, REZDIFFRA, ZENPEP, GATTEX, Cologuard Collection Kit, OCALIVA.
Industry payments across CT — which companies pay providers there.
